|
Posatex
|
-
|
EU/2/08/081/001
|
Intervet International B.V, Nīderlande
|
QS02CA91
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
ear drops, suspension
|
| International name (active substance): |
Mometasone fuorate,Posaconazole,Orbifloxacin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
SP Bray, Īrija
|
| Date of authorisation/renewal: |
23-Jun-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/081/001 |
|
1 |
ABPE pudele, 8,8 ml |
-
|
|
|
Nobilis Influenza H5N2
|
-
|
EU/2/06/061/004
|
Intervet International Booxmer, Nīderlande
|
QI01AA23
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated whole avian influenza virus antigen of H5N2 subtype
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
22-Jun-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/06/061/004 |
|
1 |
Polietilēna pudele, 500 ml |
-
|
|
|
Porcilis ColiClos
|
-
|
EU/2/12/141/004
|
Intervet International B.V., Nīderlande
|
QI09AB08
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
F4ab (K88ab) fimbrial adhesin,F5 (K99) fimbrial adhesin,F4ac (K88ac) fimbrial adhesin,Echerichia coli LT toxoid,F6 fimbrial adhesin of E. coli,Toxoid Clostridium perfringens, type C
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
14-Jun-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/141/004 |
200 deva |
1 |
Flakons, 200 deva |
-
|
|
|
Eurican L4
|
-
|
EU/2/23/293/001
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI07AB01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated, Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated, Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated, Leptospira interrogans, serogroup Australis, serovar Bratislava, strain 16785, Inactivated
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
31-Mar-2023
|
| Marketing authorisation valid until: |
30-Mar-2028
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/23/293/001 |
|
10 |
Stikla flakons, 1 ml |
-
|
|
|
Credelio Plus
|
-
|
EU/2/21/271/009
|
Elanco GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
14-Apr-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/271/009 |
|
1 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Veraflox
|
25 mg/ml
|
EU/2/10/107/013
|
Bayer Animal Health , Vācija
|
QJ01MA97
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Pradofloxacin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
07-Jan-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/10/107/013 |
25 mg/ml |
1 |
Pudelīte, 15 ml |
-
|
|
|
Emepax 24 mg
|
24 mg
|
EU/2/26/363/004
|
Axience, Francija
|
QA04AD90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Maropitant citrate monohydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
26-Mar-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/363/004 |
|
5 |
OPA/Al/PVH-Al blisteris, 4 tablete |
-
|
|
|
Bravecto
|
112.5 mg
|
EU/2/13/158/001
|
Intervet International B.V., Nīderlande
|
QP53BE02
|
very small dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet GesmbH, Austrija;Intervet Productions S.A., Francija
|
| Date of authorisation/renewal: |
13-Feb-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/158/001 |
112,5 mg |
1 |
Blisteris, 1 tablete |
-
|
|
|
Improvac
|
-
|
EU/2/09/095/005
|
Zoetis Belgium S.A., Beļģija
|
QG03XA91
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Gonadorelin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer Animal Health s.a., Beļģija
|
| Date of authorisation/renewal: |
10-Apr-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/095/005 |
|
1 |
Polietilēna pudele, 100 ml |
-
|
|
|
Bravecto
|
500 mg
|
EU/2/13/158/027
|
Intervet International B.V., Nīderlande
|
QP53B
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet UK Ltd, Lielbritānija
|
| Date of authorisation/renewal: |
13-Feb-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/158/027 |
500 mg |
2 |
Pipete, 1 deva |
-
|
|
|
Lotilaner Elanco
|
112 mg
|
EU/2/22/288/004
|
Elanco GmbH, Vācija
|
QP53BE04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S., Francija
|
| Date of authorisation/renewal: |
13-Sep-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/288/004 |
112 mg |
1 |
Blisteris, 3 tablete |
-
|
|
|
Inflacam
|
330.0 mg/deva
|
EU/2/11/134/021
|
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
QM01AC06
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
granules
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
09-Nov-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/11/134/021 |
330 mg/deva |
100 |
Papīra/PE/Al folijas/PE paciņa, 1,5 g |
-
|
|
|
CircoMax Myco
|
-
|
EU/2/20/264/006
|
Zoetis Belgium S.A., Beļģija
|
QI09AL08
|
fattening pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a ORF2 protein, Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein, Inactivated Mycoplasma hyopneumoniae, strain P-5722-3
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
09-Dec-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/264/006 |
|
4 |
ABPE flakons, 250 ml |
-
|
|
|
Vectormune FP ILT + AE
|
ml
|
EU/2/20/250/002
|
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
-
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live recombinant fowlpox virus, Avian encephalomyelitis virus, strain Calnek 1143 (AE)
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
| Date of authorisation/renewal: |
24-Apr-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/250/002 |
|
1 |
Stikla flakons, 2000 devas/flakonā |
-
|
|
|
Equioxx
|
57 mg
|
EU/2/08/083/006
|
AUDEVARD , Francija
|
QM01AH90
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
06-Jun-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/083/006 |
57 mg |
1 |
PVH/Al blisteris (caurspīdīgs), 10 tablete |
-
|
|
|
Senvelgo
|
15 mg/ml
|
EU/2/23/305/001
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QA10BK90
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Oral solution
|
| International name (active substance): |
Velagliflozin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
20-Nov-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/23/305/001 |
|
1 |
ABPE pudele, 30 ml |
-
|
|
|
EVICTO
|
240 mg
|
EU/2/19/242/019
|
VIRBAC, Francija
|
QP54AA05
|
dogs 20,1–40,0 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
VIRBAC, Francija
|
| Date of authorisation/renewal: |
19-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/242/019 |
120 mg/ml |
1 |
Polipropilēna pipete, 2 ml |
-
|
|
|
FRONTPRO
|
68 mg
|
EU/2/19/240/011
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
Dogs >10–25 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
20-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/240/011 |
68 mg |
1 |
PVH/Aclar/Al blisteris, 6 tablete |
-
|
|
|
Coxatab
|
225 mg
|
EU/2/22/286/022
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
12-Aug-2022
|
| Marketing authorisation valid until: |
11-Aug-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/286/022 |
225 mg/tabl. |
1 |
alumīnija/PVC/PE/PVDC blisteris, 50 tablete |
-
|
|
|
Circovac
|
-
|
EU/2/07/075/002
|
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
QI09AA07
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated recombinant Porcine Circovirus type 2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
MERIAL Laboratoire Porte des Alpes, Francija;Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
| Date of authorisation/renewal: |
21-Jun-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/07/075/002 |
|
10 |
Stikla flakons, 10 ml |
-
|
|